161 related articles for article (PubMed ID: 28254228)
1. Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions.
Lee KC; Lin H; ChangChien CC; Fu HC; Tsai CC; Wu CH; Ou YC
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):62-67. PubMed ID: 28254228
[TBL] [Abstract][Full Text] [Related]
2. Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center.
Tan KL; Tan WS; Lim JF; Eu KW
Int J Colorectal Dis; 2010 Feb; 25(2):233-8. PubMed ID: 19705132
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer.
Lin YH; Wu CH; Fu HC; Chen YJ; Chen YY; Ou YC; Lin H
Cancer Biomark; 2020; 28(3):285-292. PubMed ID: 32390605
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience.
Zhou R; Liu Y; Wang Y; Huo X; Zhu J; Zhang T
Int J Clin Oncol; 2020 Oct; 25(10):1822-1829. PubMed ID: 32591962
[TBL] [Abstract][Full Text] [Related]
5. Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.
Mehta AM; Bignell MB; Alves S; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Dis Colon Rectum; 2017 Jul; 60(7):691-696. PubMed ID: 28594718
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.
Lee SJ; Lee J; Lim HY; Kang WK; Choi CH; Lee JW; Kim TJ; Kim BG; Bae DS; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Jul; 66(2):229-35. PubMed ID: 19820936
[TBL] [Abstract][Full Text] [Related]
7. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall.
Lewis MR; Euscher ED; Deavers MT; Silva EG; Malpica A
Gynecol Oncol; 2007 May; 105(2):395-8. PubMed ID: 17335881
[TBL] [Abstract][Full Text] [Related]
8. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
[TBL] [Abstract][Full Text] [Related]
11. [Adnexal tumors after surgical treatment of colorectal cancer].
Gottwald L; Korczyński J; Góra E; Bieńkiewicz A
Ginekol Pol; 2008 Apr; 79(4):259-63. PubMed ID: 18592863
[TBL] [Abstract][Full Text] [Related]
12. Minilaparotomy, Cyfra21-1, and Other Predicting Factors for Suboptimal Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer: A Pilot Study.
Nantasupha C; Pojchamarnwiputh S; Charoenkwan K
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4119-4124. PubMed ID: 36579993
[TBL] [Abstract][Full Text] [Related]
13. Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level.
Obeidat B; Latimer J; Crawford R
Gynecol Obstet Invest; 2004; 57(3):153-6. PubMed ID: 14726621
[TBL] [Abstract][Full Text] [Related]
14. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer.
Everett EN; Heuser CC; Pastore LM; Anderson WA; Rice LW; Irvin WP; Taylor PT
Am J Obstet Gynecol; 2005 Aug; 193(2):568-74; discussion 574-6. PubMed ID: 16098898
[TBL] [Abstract][Full Text] [Related]
15. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
16. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
17. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
Kim HS; Bristow RE; Chang SJ
Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
[TBL] [Abstract][Full Text] [Related]
18. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival in pseudo-Meigs' syndrome caused by ovarian metastases from colon cancer.
Tajima Y; Kameyama H; Yamada S; Yagi R; Nakano M; Nagahashi M; Shimada Y; Sakata J; Kobayashi T; Umezu H; Wakai T
World J Surg Oncol; 2016 Nov; 14(1):286. PubMed ID: 27842595
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
